Benocyclidine
Benocyclidine (pronounced: ben-o-cyc-li-deen), also known as BTCP, is a dissociative anaesthetic drug with hallucinogenic effects. It is classified as a dopamine reuptake inhibitor and NMDA receptor antagonist.
Etymology
The term "Benocyclidine" is derived from the chemical structure of the compound, which consists of a benzene ring (beno-) attached to a cyclohexyl ring (-cycl-), and a piperidine ring (-idine).
Pharmacology
Benocyclidine acts primarily as a dopamine reuptake inhibitor, increasing the levels of dopamine in the brain. This results in increased stimulation of dopamine receptors, which can lead to effects such as increased energy, euphoria, and altered perception.
In addition to its effects on dopamine, Benocyclidine is also an NMDA receptor antagonist, which means it blocks the action of the NMDA receptor, a type of glutamate receptor that is involved in learning and memory. This can result in dissociative effects, including feelings of detachment from one's body and environment.
Related Terms
- Dissociative
- Anaesthetic
- Hallucinogenic
- Dopamine reuptake inhibitor
- NMDA receptor antagonist
- Dopamine
- NMDA receptor
See Also
External links
- Medical encyclopedia article on Benocyclidine
- Wikipedia's article - Benocyclidine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski